Report Detail

Request for Sample of this report

Pharma & Healthcare Global Recombinant Proteins Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4669032
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Proteins market size was valued at US$ 1430 million in 2025 and is forecast to a readjusted size of US$ 3276 million by 2032 with a CAGR of 12.7% during review period.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
This report is a detailed and comprehensive analysis for global Recombinant Proteins market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Proteins market size and forecasts, in consumption value ($ Million), 2021-2032
Global Recombinant Proteins market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Recombinant Proteins market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Recombinant Proteins market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Proteins
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Proteins market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Recombinant Proteins market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Market segment by players, this report covers
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Recombinant Proteins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Recombinant Proteins, with revenue, gross margin, and global market share of Recombinant Proteins from 2021 to 2026.
Chapter 3, the Recombinant Proteins competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Recombinant Proteins market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Proteins.
Chapter 13, to describe Recombinant Proteins research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Recombinant Proteins by Type
    • 1.3.1 Overview: Global Recombinant Proteins Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Recombinant Proteins Consumption Value Market Share by Type in 2025
    • 1.3.3 Hormones
    • 1.3.4 Growth Factors
    • 1.3.5 Cytokines
    • 1.3.6 Plasma Protein Factor
    • 1.3.7 Recombinant Metabolic Enzymes
    • 1.3.8 Immune Checkpoint Regulators
    • 1.3.9 Others
  • 1.4 Global Recombinant Proteins Market by Application
    • 1.4.1 Overview: Global Recombinant Proteins Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biopharmaceutical Companies
    • 1.4.3 Academic and Research Institutes
    • 1.4.4 Contract Research Organizations
  • 1.5 Global Recombinant Proteins Market Size & Forecast
  • 1.6 Global Recombinant Proteins Market Size and Forecast by Region
    • 1.6.1 Global Recombinant Proteins Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Recombinant Proteins Market Size by Region, (2021-2032)
    • 1.6.3 North America Recombinant Proteins Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Recombinant Proteins Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Recombinant Proteins Market Size and Prospect (2021-2032)
    • 1.6.6 South America Recombinant Proteins Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Recombinant Proteins Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Bio-Techne Corporation
    • 2.1.1 Bio-Techne Corporation Details
    • 2.1.2 Bio-Techne Corporation Major Business
    • 2.1.3 Bio-Techne Corporation Recombinant Proteins Product and Solutions
    • 2.1.4 Bio-Techne Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bio-Techne Corporation Recent Developments and Future Plans
  • 2.2 Abcam PLC
    • 2.2.1 Abcam PLC Details
    • 2.2.2 Abcam PLC Major Business
    • 2.2.3 Abcam PLC Recombinant Proteins Product and Solutions
    • 2.2.4 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abcam PLC Recent Developments and Future Plans
  • 2.3 Merck KGaA
    • 2.3.1 Merck KGaA Details
    • 2.3.2 Merck KGaA Major Business
    • 2.3.3 Merck KGaA Recombinant Proteins Product and Solutions
    • 2.3.4 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck KGaA Recent Developments and Future Plans
  • 2.4 Miltenyi Biotec
    • 2.4.1 Miltenyi Biotec Details
    • 2.4.2 Miltenyi Biotec Major Business
    • 2.4.3 Miltenyi Biotec Recombinant Proteins Product and Solutions
    • 2.4.4 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Miltenyi Biotec Recent Developments and Future Plans
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Recombinant Proteins Product and Solutions
    • 2.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.6 ACROBiosystems
    • 2.6.1 ACROBiosystems Details
    • 2.6.2 ACROBiosystems Major Business
    • 2.6.3 ACROBiosystems Recombinant Proteins Product and Solutions
    • 2.6.4 ACROBiosystems Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 ACROBiosystems Recent Developments and Future Plans
  • 2.7 Sino Biological
    • 2.7.1 Sino Biological Details
    • 2.7.2 Sino Biological Major Business
    • 2.7.3 Sino Biological Recombinant Proteins Product and Solutions
    • 2.7.4 Sino Biological Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sino Biological Recent Developments and Future Plans
  • 2.8 Cytiva
    • 2.8.1 Cytiva Details
    • 2.8.2 Cytiva Major Business
    • 2.8.3 Cytiva Recombinant Proteins Product and Solutions
    • 2.8.4 Cytiva Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Cytiva Recent Developments and Future Plans
  • 2.9 Eurogentec
    • 2.9.1 Eurogentec Details
    • 2.9.2 Eurogentec Major Business
    • 2.9.3 Eurogentec Recombinant Proteins Product and Solutions
    • 2.9.4 Eurogentec Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Eurogentec Recent Developments and Future Plans
  • 2.10 GenScript Biotech Corporation
    • 2.10.1 GenScript Biotech Corporation Details
    • 2.10.2 GenScript Biotech Corporation Major Business
    • 2.10.3 GenScript Biotech Corporation Recombinant Proteins Product and Solutions
    • 2.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 GenScript Biotech Corporation Recent Developments and Future Plans
  • 2.11 Reprocell
    • 2.11.1 Reprocell Details
    • 2.11.2 Reprocell Major Business
    • 2.11.3 Reprocell Recombinant Proteins Product and Solutions
    • 2.11.4 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Reprocell Recent Developments and Future Plans
  • 2.12 BPS Bioscience
    • 2.12.1 BPS Bioscience Details
    • 2.12.2 BPS Bioscience Major Business
    • 2.12.3 BPS Bioscience Recombinant Proteins Product and Solutions
    • 2.12.4 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 BPS Bioscience Recent Developments and Future Plans
  • 2.13 Abnova Corporation
    • 2.13.1 Abnova Corporation Details
    • 2.13.2 Abnova Corporation Major Business
    • 2.13.3 Abnova Corporation Recombinant Proteins Product and Solutions
    • 2.13.4 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Abnova Corporation Recent Developments and Future Plans
  • 2.14 ProSpec Tany TechnoGene
    • 2.14.1 ProSpec Tany TechnoGene Details
    • 2.14.2 ProSpec Tany TechnoGene Major Business
    • 2.14.3 ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
    • 2.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ProSpec Tany TechnoGene Recent Developments and Future Plans
  • 2.15 Ajinomoto
    • 2.15.1 Ajinomoto Details
    • 2.15.2 Ajinomoto Major Business
    • 2.15.3 Ajinomoto Recombinant Proteins Product and Solutions
    • 2.15.4 Ajinomoto Recombinant Proteins Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Ajinomoto Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Recombinant Proteins Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Recombinant Proteins by Company Revenue
    • 3.2.2 Top 3 Recombinant Proteins Players Market Share in 2025
    • 3.2.3 Top 6 Recombinant Proteins Players Market Share in 2025
  • 3.3 Recombinant Proteins Market: Overall Company Footprint Analysis
    • 3.3.1 Recombinant Proteins Market: Region Footprint
    • 3.3.2 Recombinant Proteins Market: Company Product Type Footprint
    • 3.3.3 Recombinant Proteins Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Recombinant Proteins Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Recombinant Proteins Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Recombinant Proteins Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Recombinant Proteins Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Recombinant Proteins Consumption Value by Type (2021-2032)
  • 6.2 North America Recombinant Proteins Market Size by Application (2021-2032)
  • 6.3 North America Recombinant Proteins Market Size by Country
    • 6.3.1 North America Recombinant Proteins Consumption Value by Country (2021-2032)
    • 6.3.2 United States Recombinant Proteins Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Recombinant Proteins Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Recombinant Proteins Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Recombinant Proteins Consumption Value by Type (2021-2032)
  • 7.2 Europe Recombinant Proteins Consumption Value by Application (2021-2032)
  • 7.3 Europe Recombinant Proteins Market Size by Country
    • 7.3.1 Europe Recombinant Proteins Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Recombinant Proteins Market Size and Forecast (2021-2032)
    • 7.3.3 France Recombinant Proteins Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Recombinant Proteins Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Recombinant Proteins Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Recombinant Proteins Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Recombinant Proteins Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Recombinant Proteins Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Recombinant Proteins Market Size by Region
    • 8.3.1 Asia-Pacific Recombinant Proteins Consumption Value by Region (2021-2032)
    • 8.3.2 China Recombinant Proteins Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Recombinant Proteins Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Recombinant Proteins Market Size and Forecast (2021-2032)
    • 8.3.5 India Recombinant Proteins Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Recombinant Proteins Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Recombinant Proteins Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Recombinant Proteins Consumption Value by Type (2021-2032)
  • 9.2 South America Recombinant Proteins Consumption Value by Application (2021-2032)
  • 9.3 South America Recombinant Proteins Market Size by Country
    • 9.3.1 South America Recombinant Proteins Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Recombinant Proteins Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Recombinant Proteins Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Recombinant Proteins Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Recombinant Proteins Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Recombinant Proteins Market Size by Country
    • 10.3.1 Middle East & Africa Recombinant Proteins Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Recombinant Proteins Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Recombinant Proteins Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Recombinant Proteins Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Recombinant Proteins Market Drivers
  • 11.2 Recombinant Proteins Market Restraints
  • 11.3 Recombinant Proteins Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Recombinant Proteins Industry Chain
  • 12.2 Recombinant Proteins Upstream Analysis
  • 12.3 Recombinant Proteins Midstream Analysis
  • 12.4 Recombinant Proteins Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Recombinant Proteins. Industry analysis & Market Report on Recombinant Proteins is a syndicated market report, published as Global Recombinant Proteins Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Recombinant Proteins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo